Recording of the webinar ‘How do different countries make decisions on reimbursing new medicines?’ held by MPE on 2nd April 2025, and given by Tom Belleman, PhD candidate at the Erasmus School of Health Policy and Management (ESHPM), Erasmus University Rotterdam.
The webinar was held as part of the Horizon Europe ASCERTAIN, an EU funded project working to promote access to medicines through the development of open access policy tools, including pricing and value assessment models.
The webinar was held as part of the Horizon Europe ASCERTAIN, an EU funded project working to promote access to medicines through the development of open access policy tools, including pricing and value assessment models.
-
Webinar | ‘How do different countries make decisions on reimbursing new medicines?’
-
Webinar EYMPG | Myeloma and physical fitness
-
MPE webinar: ASH 2024 myeloma and AL amyloidosis highlights
-
Webinar EYMPG | Importance of good nutrition and healthy diet for young myeloma patients
-
MPE webinar | Disease and treatment specificities for young myeloma patients
-
MPE Webinar | EHA 2024 myeloma highlights
-
MPE and ALAN webinar | Patient and clinician involvement in the EU HTA regulation
-
MPE/ALAN Webinar | EU HTA
-
MPE webinar | AL amyloidosis treatment updates and patient experiences
-
Webinar | Basics of medicines pricing in Europe
-
European Young Myeloma Patients Group launch event
-
MPE Webinar ASH 2023 myeloma and AL amyloidosis highlights